12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Kyowa Hakko Kirin sales and marketing update

Kyowa launched Nplate romiplostim in Taiwan to treat chronic idiopathic thrombocytopenic purpura (ITP). Kyowa said the reimbursed price of the product is NT$18,816...

Read the full 103 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >